Jul. 10 at 11:00 PM
Could
$BE theoretically be overstating its scandium supply position? Yes.
But the idea that Brookfield, Oracle, and Nebius all committed billions without uncovering a fatal supply constraint seems highly unlikely.
Bloom stated in an SEC filing that it has sufficient non-China scandium supply for current demand and backlog, with visibility to support 25 GW of annual production.
Key commitments include:
Brookfield expanding its partnership to
$25B
Nebius committing up to
$2.6B
Oracle contracting an initial 1.2 GW under an agreement covering up to 2.8 GW
External scandium estimates are difficult because Bloom’s material usage, manufacturing yields, inventory, supplier agreements, and future efficiency gains are not publicly known.
The debate continues, but major partners making long-term commitments is a meaningful data point.
Follow the filings, supply chain developments, and execution — then make your own decision.
